The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: Survey results from members of the society of gynecologic oncologists, a 5-year follow-up
Sign Up to like & getrecommendations! Published in 2017 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2017.02.005
Abstract: Highlights • NACT use among SGO members for ovarian cancer is explored given recent trials.• Fewer SGO members feel they can't predict optimal cytoreduction pre-operatively.• Laparoscopy use has increased both for diagnosis and treatment of… read more here.
Keywords: chemotherapy management; sgo members; ovarian cancer; neoadjuvant chemotherapy ... See more keywords
Chemotherapy in the management of periosteal osteosarcoma: A narrative review
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Bone Oncology"
DOI: 10.1016/j.jbo.2021.100389
Abstract: Highlights • Chemotherapy should be suggested to patients with high-risk characteristics.• Chemotherapy should be discussed for tumor downsizing before excisional surgery.• Further studies are needed to identify potential predictive biomarkers in PO patients. read more here.
Keywords: chemotherapy; narrative review; chemotherapy management; periosteal osteosarcoma ... See more keywords
Perspectives on chemotherapy for the management of double-hit lymphoma
Sign Up to like & getrecommendations! Published in 2020 at "Expert Opinion on Pharmacotherapy"
DOI: 10.1080/14656566.2020.1727445
Abstract: ABSTRACT Introduction Double-hit (DHL) and triple-hit lymphomas (THL) have long been among the most clinically aggressive molecular subtypes of diffuse large B-cell lymphomas. In the 2016 revised WHO classification, they represent a new entity called… read more here.
Keywords: lymphoma; double hit; perspectives chemotherapy; chemotherapy management ... See more keywords